Biotech may have its own ASVDA-like formulation. This is apparently trend-setting. If this extends, then we can have the medical or the bio sciences you said, and things like that, the green tech or whatever to follow this. For the medical and for bio things like that they’re also designing a very similar structure, but that’s still in the works.